Cargando…
Rationale and design of a randomised trial of trientine in patients with hypertrophic cardiomyopathy
AIMS: Hypertrophic cardiomyopathy (HCM) is characterised by left ventricular hypertrophy (LVH), myocardial fibrosis, enhanced oxidative stress and energy depletion. Unbound/loosely bound tissue copper II ions are powerful catalysts of oxidative stress and inhibitors of antioxidants. Trientine is a h...
Autores principales: | Farrant, John, Dodd, Susanna, Vaughan, Carly, Reid, Anna, Schmitt, Matthias, Garratt, Clifford, Akhtar, Mohammed, Mahmod, Masliza, Neubauer, Stefan, Cooper, Robert M, Prasad, Sanjay K, Singh, Anvesha, Valkovič, Ladislav, Raman, Betty, Ashkir, Zakariye, Clayton, Dannii, Baroja, Olatz, Duran, Beatriz, Spowart, Catherine, Bedson, Emma, Naish, Josephine H, Harrington, Chris, Miller, Christopher A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359575/ https://www.ncbi.nlm.nih.gov/pubmed/37137675 http://dx.doi.org/10.1136/heartjnl-2022-322271 |
Ejemplares similares
-
Role of Trientine in Hypertrophic Cardiomyopathy: A Review of Mechanistic Aspects
por: Ramli, Fitri Fareez, et al.
Publicado: (2022) -
Mechanisms and prognostic impact of myocardial ischaemia in hypertrophic cardiomyopathy
por: Coleman, James A., et al.
Publicado: (2023) -
Design and rationale of the EMPA‐VISION trial: investigating the metabolic effects of empagliflozin in patients with heart failure
por: Hundertmark, Moritz J., et al.
Publicado: (2021) -
ABNORMAL SKELETAL METABOLISM BUT NOT CARDIAC DYSFUNCTION AS A CAUSE FOR FATIGUE POST COVID-19
por: Cassar, Mark Philip, et al.
Publicado: (2023) -
Four-dimensional flow cardiac magnetic resonance assessment of left ventricular diastolic function
por: Ashkir, Zakariye, et al.
Publicado: (2022)